Abstract:Objectives: The interaction between the components of traditional Chinese medicine (TCM) is an important basis for their synergy. Rhein and curcumin exert various pharmacological activities, including anti-tumour, anti-inflammatory, antioxidant, anti-fibrosis and renoprotective effects. However, no investigation has reported the synergistic anti-fibrosis effect yet. This study aims at determine the pharmacokinetics and pharmacodynamics of the combination of rhein and curcumin in the treatment for chronic kidney disease in rats. Design: Fifty two male Sprague-Dawley (SD) rats were randomly divided into rhein group, curcumin group and their combination group for pharmacodynamics studies. HE and Masson staining was conducted to observe the changes of renal morphology. Kits were used to detect the level of urea nitrogen (BUN) and creatinine (Scr). For pharmacokinetic study, 36 SD rats were randomly divided into rhein group, curcumin group and a combination group, the content of rhein and curcumin in plasma and renal tissue was determined by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). In additon, molecular docking method and cell experiments was used to disclose the interaction mechanism between curcumin and rhein. Results: The pharmacodynamic results showed that the degree of renal fibrosis was improved obviously by co-administration rhein and curcumin. Meanwhile, compared to single administration, the Cmax and AUC of rhein and curcumin in plasma and renal tissue were enhanced significantly after co-administration. Moreover, the result of molecular docking and cell experiments showed that both two compounds could interact with P-gp, CYP2C9 and CYP2C19. Conclusion: Together, these findings demonstrated that rhein and curcumin had a synergistic effect in ameliorateing chonic kidney disease, providing an important explanation on the synergistic mechanism of curcumin and rhein from a pharmacokinetic viewpoint.

Research Progress on the Positive and Negative Regulatory Effects of Rhein on the Kidney: A Review of Its Molecular Targets

Pharmacokinetics and Pharmacodynamics of the Combination of Rhein and Curcumin in the Treatment of Chronic Kidney Disease in Rats

Rhein: An Updated Review Concerning Its Biological Activity, Pharmacokinetics, Structure Optimization, and Future Pharmaceutical Applications

Update on Pharmacological Activities, Security, and Pharmacokinetics of Rhein

Anti-Hyperuricemic and Nephroprotective Effects of Rhein in Hyperuricemic Mice

Rhein Reverses Klotho Repression Via Promoter Demethylation and Protects Against Kidney and Bone Injuries in Mice with Chronic Kidney Disease

A research update on the therapeutic potential of rhein and its derivatives

The Molecular Mechanism of Rhein in Diabetic Nephropathy

Rhein, A Component of Rhubarb, Protects Against Oxidative Stress-Induced Renal Aging and Injury by Inhibition of TNF-α- Mediated Autophagy and Necroptosis

Rhein: A Review of Pharmacological Activities

A Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone Ingredient

Rhein Protects Against Acetaminophen-Induced Hepatic and Renal Toxicity

Rhein Improves Renal Lesion and Ameliorates Dyslipidemia in Db/Db Mice with Diabetic Nephropathy

Updated Pharmaceutical Progress on Plant Antibiotic Rhein and Its Analogs:Bioactivities, Structure–activity Relationships and Future Perspectives

Rhein Reversal of Dna Hypermethylation-Associated Klotho Suppression Ameliorates Renal Fibrosis in Mice

Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3α signalling pathway.

Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3 signalling pathway

Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of rhein

Rhein Protects 5/6 Nephrectomized Rat Against Renal Injury by Reducing Inflammation Via NF-κB Signaling

Pharmacology of Rhein and Advancement in the Synthesis of Its Derivatives

Rhein Inhibits Autophagy in Rat Renal Tubular Cells by Regulation of AMPK/mTOR Signaling.